Prognosis following acute coronary syndromes according to prior coronary artery bypass grafting: Meta-analysis by Teixeira, R et al.
European Heart Journal: Acute Cardiovascular Care
 1 –10
© The European Society of Cardiology 2014








Coronary artery bypass grafting (CABG) has been an estab-
lished therapy for patients with obstructive coronary artery 
disease since the 1970s, with a major impact on symptoms1 
and in some subsets on mortality and subsequent cardiovas-
cular events.2 Until the late 1990s there had been increasing 
numbers of CABGs performed annually, in Europe and in 
the USA.3 This, along with the progression of native coro-
nary atherosclerosis and saphenous vein graft disease dur-
ing long-term follow-up, has led to an increase in the 
proportion of patients with an acute coronary syndrome 
(ACS) who have previously undergone CABG.4
Post-CABG patients presenting with acute myocardial 
infarction (MI) have been shown to be older, with a greater 
proportion of diabetes, heart failure, and previous MI.5,6 
Nonetheless it has been demonstrated that they usually 
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Purpose: Conduct a meta-analysis to study the prognostic influence of a previous coronary artery bypass grafting 
(CABG) in patients admitted for an acute coronary syndrome (ACS).
Methods: A systematic review of the literature was performed using electronic reference databases through January 
2013 (MEDLINE, Cochrane Library, Web of Knowledge, Google Scholar and references cited in other studies). Studies 
in which ACS outcomes with a previous history of CABG were compared with ACS outcomes with no history of 
previous CABG were considered for inclusion. The main endpoints of interest were mortality and non-fatal acute 
myocardial infarction. Data was aggregated at three follow-up times using random-effects meta-analysis models.
Results: Twenty-four studies were included which provided 387,181 patients for analysis. Previous CABG ACS patients 
were older, more diabetic and had a more frequent history of a previous myocardial infarction. Pooled in-hospital 
mortality was higher for the previous CABG ACS patients (OR 1.22 [1.04–1.44], p<0.01, I2 88%). The pooled adjusted 
OR showed no significant differences for the two groups (adjusted OR 1.13 [0.93–1.37], p=0.22, I2 92%). Previous CABG 
ACS patient had a higher pooled 30-day mortality (OR 1.28 [1.05–1.55], p=0.02, I2 74%); a higher non-adjusted (OR 1.61 
[1.38–1.88], p<0.01, I2 70%) and adjusted (adjusted OR 1.37 [1.15–1.65], p<0.01, I2 0%) long-term mortality. Both the 
in-hospital and the long-term re-infarction rates were higher for the previous CABG ACS patients.
Conclusions: According to our data, ACS patients with previous CABG history had a higher risk for short- and long-
term adverse events.
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have smaller infarcts and a lower incidence of Q-wave 
MIs.7,8 Therefore it has been hypothesized that a prior 
CABG could exert a protective effect, as a result of the dou-
ble coronary circulation and ischemic preconditioning.6,9,10
The purpose of this meta-analysis was to systematically 
review and synthesize existing data on prognosis of patients 
with ACS and a history of a previous CABG, with respect 
to in-hospital, short-term and long-term outcomes.
Methods
Search strategy for the identification of 
studies
We searched electronic databases for articles published in 
English until January 2013. Databases included MEDLINE, 
Cochrane Library (Cochrane Central Register of Controlled 
Trials), Web of Knowledge, Google Scholar and references 
cited in other studies. The medical subject headings and 
keyword searches included the terms “acute coronary syn-
drome”, “acute myocardial infarction”, “prior coronary 
arterial bypass”. Citations were screened at the title/abstract 
level and full texts were manually obtained for all poten-
tially relevant articles.
Two evaluators independently extracted all data. 
Discrepancies were resolved by consensus. Additionally, 
we signed up with PubMed to receive automated electronic 
notification for any new articles containing the above 
search terms.
Criteria for considering studies for this 
review
All published studies in which ACS outcomes with a previous 
history of CABG were compared with ACS outcomes with 
no history of previous CABG, were considered for inclusion 
in this meta-analysis. Our pre-specified inclusion criteria 
were as follows: the studies should compare ACS outcomes 
among patients with and without prior CABG. Moreover, the 
ACS should not be related to the immediate postoperative 
period. The study design could have been observational 
(either single or multicenter and either prospective or retro-
spective data) or as a post hoc analyzes of randomized con-
trolled trials (RCTs). Exclusion criteria were duplicate 
publication; ongoing/unpublished study and studies pub-
lished only as an abstract or in conference proceedings.
Identification
The MeSH headings strategy yielded 1969 publications. 
One additional publication was identified after searching the 
reference lists of the relevant publications. Over 1473 publi-
cations were excluded because it was clear from the title and 
abstract that they did not fulfil the selection criteria. Two 
reviewers independently selected the studies to be included, 
in accordance with the described selection criteria, and read 
the remaining 27 articles in full. Three studies were 
excluded.7,11,12 Twenty-four studies were finally included in 
the meta-analysis, see Table 1 and Supplemental Figure 1.
Methods of review
The following information was extracted from relevant 
studies: study design, study characteristics, patient charac-
teristics (age, gender, history of diabetes, and previous MI), 
admission diagnosis, and patient management (invasive/
conservative strategy; in-hospital medical therapy; percuta-
neous coronary intervention (PCI), fibrinolysis). The end-
points of interest were in-hospital, short-term and long-term 
total mortality. Short-term included mortality from dis-
charge to 30 days and long-term included mortality from 90 
days to 9.5 years of follow-up.
With respect to in-hospital management, we also ana-
lyzed the pooled data for cardiogenic shock, stroke, and 
major bleeding rate for both groups. Re-infarction was also 
analyzed in two separate results: in-hospital and long-term 
follow-up that included data from 6 months to 9.5 years of 
follow-up.
Statistical analysis
We used RevMan 5.022 (Nordic Cochrane Centre, 
København, Denmark) to estimate pooled odds ratio 
(OR) based on random effects model meta-analysis 
(inverse variance method). We assumed similarity 
between the relative risk and OR. Whenever possible we 
used pooled adjusted relative risk or OR from the primary 
studies; otherwise, we used raw outcome data to yield 
unadjusted the ORs. The standard error of the adjusted 
ORs was calculated according to the formula: [ln(upper 
95%CI) – ln(OR)] / 1.96. In view of the potential diver-
sity of study designs, we chose to stratify data for in-
hospital mortality, based on admission diagnosis and the 
type of study. The following grouping was elaborated: i) 
admission diagnosis: studies that included only ST- or 
only non-ST-elevation ACS patients; ii) study design: 
stratification was done for post hoc RCTs and post hoc 
multicenter registries data; and iii) studies publication 
date: publication before 2000; publication between 2000 
and 2010; publication after 2010. Statistical heterogene-
ity was assessed using the I2 statistic, and values of 30–
60% represented a moderate level of heterogeneity. 
Publication bias was estimated visually with funnel plots.
Results
The search results yielded 24 relevant studies with 387,181 
patients. They comprised nine post hoc analyses of RCTs, 
11 multicenter registries, and four single centre studies. The 
main characteristics of the included studies are described in 
Table 1.
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Regarding baseline characteristics, the pooled data asso-
ciated previous CABG ACS patients with an older age 
(mean difference +2.88 years [1.35–4.41], I2 99%) and with 
male gender (OR 1.56 [1.43–1.71], I2 90%). Regarding 
admission diagnosis, non-ST-elevation ACS was more fre-
quent for patients with a previous CABG history. The 
pooled data identified a higher prevalence of diabetes (OR 
1.75 [1.57–1.95], I2 94%) and of previous MI (OR 5.70 
[4.69–6.94], I2 98%) in the CABG ACS patients. Moreover, 
the previous CABG ACS patients also had a lower pooled 
left ventricular ejection fraction (mean difference -6.46% 
[-8.71–4.21], I2 98%) (Table 2).
In-hospital mortality
Fourteen studies were included in the pooled analysis of in-
hospital all-cause mortality. During hospital stay 2854 
(8.8%) of 32,060 previous CABG patients died, compared 
with 21,354 (7.6%) of 282,603 in the no previous CABG 
history patients (OR 1.22 [1.04–1.44], p<0.01, I2 88%) 
(Figure 1(a)). The difference remained significant for the 
studies that included only ST-elevation ACS patients (OR 
1.39 [1.17–1.65], p<0.01, I2 68%). For studies that included 
only non-ST-elevation ACS patients, there were no signifi-
cant differences between the groups (OR 1.01 [0.70–1.44], 
p=0.97, I2 94%) (Supplemental Figure 2(a)). With respect to 
the design of the study, the pooled data from RCTs identified 
a worse prognosis for the previous CABG ACS patients (OR 
1.36 [1.06–1.73], p=0.01, I2 16%), that was in contrast with 
data from observational multicenter registries (OR 1.22 
[0.96–1.54], p=0.1, I2 92%) (Supplemental Figure 2(b)). 
Regarding publication date, we noted a worse prognosis for 
the previous CABG ACS patients in studies published before 
2000 (OR 1.44 [1.04–2.00], p=0.03, I2 58%). A similar in-
hospital mortality was noted for studies published between 
2000 and 2010, and after 2010 (Supplemental Figure 2(c)). 
Finally the pooled adjusted OR available for only six trials, 
with a total of 173,826 patients, concluded that there were no 
significant differences for the two groups regarding in-hospi-
tal adjusted mortality (adjusted OR 1.13 [0.93–1.37], p=0.22, 
I2 92%) (Figure 1(b)).
In-hospital management and morbidity
With respect to in-hospital management, ACS patients with 
a history of a previous CABG had a lower pooled probabil-
ity of a percutaneous coronary intervention during hospital 
stay (OR 0.75 [0.63–0.90], p<0.01, I2 96%) (Figure 2(a)); 
and a lower pooled rate of in-hospital fibrinolysis (OR 0.44 
[0.34–0.57], p<0.01, I2 93%) (Supplemental Figure 3(a)). 
Cardiogenic shock was significantly more frequent in the 
previous CABG history patients (OR 1.52 [1.34–1.74], 
p<0.01, I2 0%) (Figure 2(b)). Previous CABG patients had 
a higher rate of in-hospital re-infarction (OR 1.41 [1.09–
1.83], p<0.01, I2 31%) (Figure 2(c)). There were no signifi-
cant differences between groups with respect to stroke and 
in-hospital major bleeding rates (Supplemental Figure 3(b) 
and (c), respectively).
Short and long-term data
With respect to 30-day mortality, data was available from 12 
studies including 130,099 patients. Over 570 of 9374 (6.1%) 
previous CABG patients died, in comparison with 6436 
Table 2. Pooled baseline characteristics and in-hospital medical therapy.
Mean difference Number of patients included I2
 Previous CABG 
ACS patients
No previous CABG 
ACS patients
Age (years) 2.88 (1.35–4.41) 20,746 166,236 99
LVEF (%) −6.46 (−8.71 to −4.21) 17,206 101,539 98
 Pooled OR Previous CABG 
ACS patients
No previous CABG 
ACS patients
I2
ST-elevation ACS 0.22 (0.11–0.43) 4880 / 18,444 52,547 / 129,998 99
Non-ST-elevation ACS 3.45 (1.96–6.09) 13,458 / 18,444 77,312 / 129,998 98
Male gender 1.56 (1.43–1.71) 29,818 / 40,392 222,812 / 336,592 90
Diabetes 1.75 (1.57–1.95) 15,373 / 39,344 84,118 / 334,743 94
Previous MI 5.70 (4.69–6.94) 21,715 / 39,279 65,685 / 332,165 98
Aspirin 0.96 (0.74–1.23) 15,841 / 19,364 135,515 / 157,612 95
Second AAP 0.88 (0.71–1.09) 14,070 / 17,627 101,510 / 134,918 94
IIb/IIIa inhibitors 0.94 (0.61–1.44) 1635/ 16,137 16,498 / 97,984 97
Beta-blockers 0.95 (0.81–1.10) 9767 / 19,236 80,129 / 151,995 93
ACEi / ARA 1.05 (0.82–1.36) 1116 / 2198 23,556 / 45,094 83
AAP: antiplatelet therapy; ACEi: angiotensin converting enzyme inhibitors; ACS: acute coronary syndrome; ARA: angiotensin II receptor antagonist; 
CABG: coronary artery bypass grafting; MI: myocardial infarction; LVEF: left ventricular ejection fraction; I2: study heterogeneity.
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from 11,4619 (5.6%) with no previous CABG ACS patients. 
These pooled data was statistically significant (OR 1.28 
[1.05–1.55], p=0.02, I2 74%) (Supplemental Figure 4(a)). 
Long-term mortality data was available from 12 studies, 
with a total of 8590 events. Previous CABG history was 
associated with a significant worse long-term mortality (OR 
1.61 [1.38–1.88], p<0.01, I2 70%) (Figure 3(a)).
Adjusted data was available for four studies, which 
allowed an estimation of an adjusted pooled OR. Even after 
adjustment, previous CABG was associated with a higher 
rate of long-term mortality (adjusted OR 1.37 [1.15–1.65], 
p<0.01, I2 0%) (Figure 3(b)).
With respect to long-term re-infarction rate, data was 
available for 33,160 patients with a total of 2536 events. 
Previous CABG history patients were more likely to have a 
re-infarction during follow-up (OR 1.88 [1.44–2.46], 
p<0.01, I2 80%) (Supplemental Figure 4(b)).
Discussion
According to our pooled data, previous CABG patients 
admitted for an ACS had a worse prognosis, especially for 
the long-term.
The impact of prior CABG on survival after an ACS is a 
controversial subject. Previous studies from the 1990s 13 
and the 2000s6,9 have suggested that patients with prior 
bypass surgery have an increased in-hospital mortality, 
which was likely because of more adverse baseline charac-
teristics in the post-CABG cohort. Our data seem to be in 
agreement. First, our baseline pooled data associated previ-
ous CABG ACS patients with an older age, and with higher 
risk variables such as diabetes, previous MI, and a lower 
LVEF. Second, our pooled adjusted OR did not confer an 
increased in-hospital mortality. This probably means that 
the higher non-adjusted in-hospital mortality of previous 
CABG patients was likely the result of older age and multi-
morbidity, and not the previous surgery itself.
We improved the inconsistency of the data regarding in-
hospital mortality by stratifying the population. In this way, 
we were able to conclude that ST-elevation previous CABG 
ACS patients had higher in-hospital mortality. It has been 
suggested that post-CABG MIs tend to be smaller in rela-
tionship with a number of factors: small vessel disease; col-
lateral circulation or native vessel disease distal to a graft.4 
Nevertheless, the presence of an ST-segment elevation is 
suggestive of a larger lesion in a form of transmural myocar-
dial injury and usually represents an acute occlusion of an 
epicardial coronary artery or of a graft. Contrary to previous 
reports,14 recent data regarding prior CABG ST-elevation 
ACS patients, reported a nearly equal distribution of the 
Figure 1. In-hospital outcome. (a) Forrest plot for in-hospital mortality. (b) Forrest plot for adjusted in-hospital mortality.
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infarct related artery, between bypass grafts and native coro-
nary vessels.15 Moreover, the graft culprit patients had a 
lower success of primary PCI, and a significantly higher rate 
of clinical events. In that same trial, over 20% of prior CABG 
patients planned for primary PCI, failed to receive reperfu-
sion, mainly because of technical limitations and for the 
inability to identify a culprit vessel. Those 20% of patients 
also had a significantly higher short-term mortality support-
ing the concept that there is no evidence of a protective effect 
of a dual coronary circulation in patients who failed to 
receive primary PCI.15 Underutilization of reperfusion thera-
pies in ST-elevation post-CABG patients has also been 
reported since the lytic era16 with significant prognostic 
implications.14 It has also been demonstrated that previous 
CABG patients have an increased total atherosclerotic bur-
den and more advanced disease overall, as well as a greater 
clot burden, and longer lesions, which are factors associated 
with a higher resistance to thrombolytic therapy.14 We believe 
our data indirectly corroborate this worse prognosis of 
ST-elevation ACS patients, not only because of the higher 
in-hospital mortality, but also the lower rate of percutaneous 
intervention and fibrinolysis in the previous CABG ACS 
patients.
Of interest was that in the non-ST-elevation ACS group 
of patients, in-hospital mortality was similar between the 
previous CABG and the rest of the ACS cohort. That was 
Figure 2. In-hospital management. (a) Forrest plot for in-hospital PCI. (b) Forrest plot for cardiogenic shock. (c) Forrest plot for 
in-hospital re-infarction.
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true despite the older age, the higher risk profile, and the 
more conservative approach. It is certainly plausible that 
the effect of the dual coronary circulation, the presence of 
collaterals, and the ischemic preconditioning could be pro-
tective. This seems especially important in the context of 
small non-transmural myocardial ischemic lesions.
Regarding in-hospital major bleeding we concluded, 
although with a high level of heterogeneity, that major 
bleeding was not significantly increased for previous 
CABG patients. Although in the past 20 years optimized 
medical therapy has improved significantly in the post-
CABG subset of patients,17 recent reports from the present 
decade concluded for a less aggressive antiplatelet and anti-
coagulation therapy in those patients, probably protecting 
them from an increased bleeding.9 Moreover, a lower rate 
of percutaneous intervention and lytic therapy could also 
have influenced this result.
Our pooled data also demonstrated that percutaneous 
revascularization was less common in post-CABG patients, 
in both ST- and non-ST-elevation cohorts. The reasons for 
this are probably diverse. Previous authors have reported 
that CABG patients during an ACS are less referred for an 
invasive strategy4 despite their increased ischemic risk, 
supporting a concept of a paradoxical strategy allocation.18 
The lower referral could be because of older age, multi-
morbidity, and previously known coronary anatomy, con-
sidered not to be amenable to further revascularization. 
Also, post-CABG patients referred for an invasive strategy 
often may not receive such therapy because of complex 
anatomy and the problems associated with interventions on 
diseased saphenous vein grafts.15 This conservative man-
agement, associated with a lower rate of arterial and saphe-
nous graft patency at 10 years after surgery,19 and a lower 
use of medical therapy,20 could also be important factors to 
explain the higher short- and long-term re-infarction rates, 
and consequently a higher long-term mortality of post-
CABG patients after an ACS. Unfortunately the majority of 
the studies did not report time from CABG to the coronary 
event. This would be important to further stratify data, as 
the different age of the grafts at the time of infarction could 
likely exert either a beneficial or deleterious effect.
Post-CABG ACS patients are a complex group of 
patients, with respect to multimorbidity, coronary anatomy, 
and revascularization. Our data was consistent with a worse 
prognosis for this ACS subset of patients, but the outcomes 
also seem to be influenced by the more adverse baseline 
Figure 3. Long-term outcomes. (a) Forrest plot for long-term mortality. (b) Forrest plot for long-term adjusted mortality.
Teixeira et al. 9
variables, for which adjustments are not complete. Whether 
the events in this ACS subset of patients can be prevented 
by a repeat revascularization procedure is still uncertain. 
Strategies should continue to be developed to minimize the 
adverse outcome of this ACS subset of patients, with 
emphasis on medical therapy, innovative percutaneous 
treatments, and minimally invasive surgical procedures.
Limitations
Our analysis is based on studies from the 1990s to 2012. 
Methodologies across the studies were not uniform regard-
ing ACS definition, medical therapy, revascularization, and 
even the surgical technique. We have included in our analy-
sis RCTs sub-analysis and observational (single and multi-
center) studies. All of these factors contributed to the 
heterogeneity in various endpoints, which influenced the 
consistency of our results. We also suspect the existence of 
publication bias, as the Funnel plots (Supplemental Figure 
5) are not symmetric.
Conclusions
Post-CABG patients had a worse outcome after an ACS, 
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